{"content":"<li class=\"n-box-item date-title\" data-end=\"1356065999\" data-start=\"1355979600\" data-txt=\"Wednesday, December 18, 2019\">Thursday, December 20, 2012</li><li class=\"n-box-item sa-box-item\" data-id=\"731991\" data-ts=\"1356049310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEB\" target=\"_blank\">HEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731991\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After struggling to make recommendations about the product, an FDA panel rejects Hemispherx...</a></h4><p>After struggling to make recommendations about the product, an FDA panel rejects Hemispherx Biopharma's (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/HEB\" title=\"Hemispherx Biopharma, Inc\">HEB</a>) chronic fatigue syndrome treatment Ampligen, saying it <a href=\"http://online.wsj.com/article/SB10001424127887324731304578191951426646118.html\" target=\"_blank\">isn't ready</a> for marketing. Several panel members struggled with their decisions because it appears the drug works in certain patients even if it wasn't strongly shown in the clinical data presented to the panel. Shares <font color=\"red\">-20%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"731991\" data-linked=\"After struggling to make recommendations about the product, an FDA panel rejects Hemispherx...\" data-tweet=\"$HEB $AIM - After struggling to make recommendations about the product, an FDA panel rejects Hemispherx Biopharma&#39;s (NYSEMKT:HEB) chronic fatigue syndrome treatment Ampligen, saying it isn&#39;t ready for marketing. Several panel members struggled with thei... https://seekingalpha.com/news/731991?source=tweet\" data-url=\"https://seekingalpha.com/news/731991\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731981\" data-ts=\"1356047874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on FuelCell Energy (NASDAQ:FCEL): FQ4 misses on the bottom line but beat on top line...</a></h4><p>More on FuelCell Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FCEL\" title=\"FuelCell Energy, Inc.\">FCEL</a>):  <a href=\"https://seekingalpha.com/market_currents/post/731951\" target=\"_blank\">FQ4 misses</a> on the bottom line but beat on top line revenue. Net losses widened over the quarter as the power-equipment maker's expenses grew. The company hasn't posted an annual profit since 1997, but its revenue has generally improved over the past year, as cheap natural gas has driven down its power-production costs and boosted demand. Product sales grew 1.7% to  $35.4M, while R&amp;D contracts increased 9.3% to $1.6M. Shares <font color=\"green\">+6%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"731981\" data-linked=\"More on FuelCell Energy (NASDAQ:FCEL): FQ4 misses on the bottom line but beat on top line...\" data-tweet=\"$FCEL - More on FuelCell Energy (NASDAQ:FCEL): FQ4 misses on the bottom line but beat on top line revenue. Net losses widened over the quarter as the power-equipment maker&#39;s expenses grew. The company hasn&#39;t posted an annual profit since 1997, but its r... https://seekingalpha.com/news/731981?source=tweet\" data-url=\"https://seekingalpha.com/news/731981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731951\" data-ts=\"1356047647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell Energy (NASDAQ:FCEL): FQ4 EPS of -$0.07 misses by $0.02. Revenue of $35.4M beats by...</a></h4><b>FuelCell Energy (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FCEL\" title=\"FuelCell Energy, Inc.\">FCEL</a>):</b> FQ4 EPS of -$0.07 <font color=\"red\">misses by $0.02</font>. Revenue of $35.4M <font color=\"green\">beats by $5M</font>. Shares <font color=\"green\">+5%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"731951\" data-linked=\"FuelCell Energy (NASDAQ:FCEL): FQ4 EPS of -$0.07 misses by $0.02. Revenue of $35.4M beats by...\" data-tweet=\"$FCEL - FuelCell Energy (NASDAQ:FCEL): FQ4 EPS of -$0.07 misses by $0.02. Revenue of $35.4M beats by $5M. Shares +5% AH. (PR) https://seekingalpha.com/news/731951?source=tweet\" data-url=\"https://seekingalpha.com/news/731951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731911\" data-ts=\"1356045212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731911\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research In Motion (RIMM) has done an about-face: shares are down 11.6% AH following its FQ3...</a></h4><p>Research In Motion (RIMM) has done an about-face: shares are <font color=\"red\">down 11.6%</font> AH following its FQ3 call. RIM mentioned its services business (36% of revenue, and a bigger share of profits) could be pressured by a pricing overhaul that will come with BB10 - it'll offer a variety of service options, and some of the basic ones won't cost much. Also, the fact RIM's subscriber base is now declining and shifting towards emerging markets will affect services revenue. The U.S., U.K., and Canada made up 36% of FQ3 sales, down from FQ2's 42%. (FQ3: <a href=\"https://seekingalpha.com/currents/post/731581\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/731611\" target=\"_blank\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"731911\" data-linked=\"Research In Motion (RIMM) has done an about-face: shares are down 11.6% AH following its FQ3...\" data-tweet=\"$BB - Research In Motion (RIMM) has done an about-face: shares are down 11.6% AH following its FQ3 call. RIM mentioned its services business (36% of revenue, and a bigger share of profits) could be pressured by a pricing overhaul that will come with BB1... https://seekingalpha.com/news/731911?source=tweet\" data-url=\"https://seekingalpha.com/news/731911\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731871\" data-ts=\"1356043933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Nike (NYSE:NKE): FQ2 beats on both top and bottom line as sales continue to grow at the...</a></h4><p>More on Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>): <a href=\"https://seekingalpha.com/market_currents/post/731591\" target=\"_blank\">FQ2 beats</a> on both top and bottom line as sales continue to grow at the retail giant. Net profit shrank 18% Y/Y however, weighed down by $137M in losses tied to the sale of its Umbro and Cole Haan brands. Regionally, growth was strongest in North America, which offset weakness in China and Western Europe. Shares <font color=\"green\">+2.7%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"731871\" data-linked=\"More on Nike (NYSE:NKE): FQ2 beats on both top and bottom line as sales continue to grow at the...\" data-tweet=\"$NKE - More on Nike (NYSE:NKE): FQ2 beats on both top and bottom line as sales continue to grow at the retail giant. Net profit shrank 18% Y/Y however, weighed down by $137M in losses tied to the sale of its Umbro and Cole Haan brands. Regionally, growt... https://seekingalpha.com/news/731871?source=tweet\" data-url=\"https://seekingalpha.com/news/731871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731851\" data-ts=\"1356043205\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: RIMM +7%. RHT +6%. NKE +5%. CAMP +4%. TIBX +4%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> RIMM <font color=\"green\">+7%</font>. <a href='https://seekingalpha.com/symbol/RHT' title='Red Hat, Inc.'>RHT</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color=\"green\">+5%</font>. <a href='https://seekingalpha.com/symbol/CAMP' title='CalAmp Corp.'>CAMP</a> <font color=\"green\">+4%</font>. <a href='https://seekingalpha.com/symbol/TIBX' title='TIBCO Software, Inc.'>TIBX</a> <font color=\"green\">+4%</font>.  <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers Inc.'>SB</a> <font color=\"red\">-14%</font>. <a href='https://seekingalpha.com/symbol/DTLK' title='Datalink Corporation'>DTLK</a> <font color=\"red\">-8%</font>. <a href='https://seekingalpha.com/symbol/BXE' title='Bellatrix Exploration Ltd'>BXE</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color=\"red\">-3%</font>. <a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas AÃ©reas Inteligentes S.A.'>GOL</a> <font color=\"red\">-2%</font>.<div class=\"tiny-share-widget\" data-id=\"731851\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: RIMM +7%. RHT +6%. NKE +5%. CAMP +4%. TIBX +4%....\" data-tweet=\"$BB $BB $RHT - After-hours top gainers, as of 5:15 p.m.: RIMM +7%. RHT +6%. NKE +5%. CAMP +4%. TIBX +4%. After-hours top losers: SB -14%. DTLK -8%. BXE -4%. MU -3%. GOL -2%. https://seekingalpha.com/news/731851?source=tweet\" data-url=\"https://seekingalpha.com/news/731851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731841\" data-ts=\"1356043015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731841\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale (NYSE:VALE) says it will take a $4.2B writedown on its nickel and aluminum investments,...</a></h4>Vale (NYSE:<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>) says it will take a <a href=\"http://www.marketwatch.com/story/vale-to-take-charge-on-nickel-aluminum-assets-2012-12-20\" target=\"_blank\">$4.2B  writedown</a> on its nickel and aluminum investments, part of a series of  charges that will hit the miner's Q4 earnings. Most of the charges are related to its troubled  Onca Puma nickel mine in Brazil, which was shuttered in June. The total charge before taxes for Onca Puma will total $2.85B. VALE <font color=\"red\">-2%</font> AH.<div class=\"tiny-share-widget\" data-id=\"731841\" data-linked=\"Vale (NYSE:VALE) says it will take a $4.2B writedown on its nickel and aluminum investments,...\" data-tweet=\"$VALE - Vale (NYSE:VALE) says it will take a $4.2B writedown on its nickel and aluminum investments, part of a series of charges that will hit the miner&#39;s Q4 earnings. Most of the charges are related to its troubled Onca Puma nickel mine in Brazil, whic... https://seekingalpha.com/news/731841?source=tweet\" data-url=\"https://seekingalpha.com/news/731841\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731781\" data-ts=\"1356040889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TIBX\" target=\"_blank\">TIBX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731781\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tibco (NASDAQ:TIBX): FQ4 EPS of $0.42 beats by $0.03. Revenue of $296.5M (+2% Y/Y) beats by $3M....</a></h4><b>Tibco (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TIBX\" title=\"TIBCO Software, Inc.\">TIBX</a>):</b> FQ4 EPS of $0.42 <font color=\"green\">beats by $0.03</font>. Revenue of $296.5M (+2% Y/Y) <font color=\"green\">beats by $3M</font>. <a target=\"_blank\" href=\"https://twitter.com/TechStockRadar/status/281879594905247744\">Expects</a> FQ1 revenue of $241M-$245M and EPS of $0.17-$0.18 vs. consensus of $240.7M and $0.21. 195 deals over $100K and 25 deals over $1M in FQ4, up from 134 over $100K and 16 over $1M in FQ3. Shares <font color=\"green\">+6.1%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"731781\" data-linked=\"Tibco (NASDAQ:TIBX): FQ4 EPS of $0.42 beats by $0.03. Revenue of $296.5M (+2% Y/Y) beats by $3M....\" data-tweet=\"$TIBX - Tibco (NASDAQ:TIBX): FQ4 EPS of $0.42 beats by $0.03. Revenue of $296.5M (+2% Y/Y) beats by $3M. Expects FQ1 revenue of $241M-$245M and EPS of $0.17-$0.18 vs. consensus of $240.7M and $0.21. 195 deals over $100K and 25 deals over $1M in FQ4, up ... https://seekingalpha.com/news/731781?source=tweet\" data-url=\"https://seekingalpha.com/news/731781\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731711\" data-ts=\"1356040074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research In Motion (RIMM) has resumed trading. Shares are up 7.1% AH, as investors give a...</a></h4><p>Research In Motion (RIMM) has resumed trading. Shares are <font color=\"green\">up 7.1%</font> AH, as investors give a thumbs-up to its <a href=\"https://seekingalpha.com/currents/post/731581\" target=\"_blank\">FQ3 beat</a>, <a href=\"https://seekingalpha.com/currents/post/731611\" target=\"_blank\">gross margin improvement</a>, and $950M in operating cash flow.</p><div class=\"tiny-share-widget\" data-id=\"731711\" data-linked=\"Research In Motion (RIMM) has resumed trading. Shares are up 7.1% AH, as investors give a...\" data-tweet=\"$BB - Research In Motion (RIMM) has resumed trading. Shares are up 7.1% AH, as investors give a thumbs-up to its FQ3 beat, gross margin improvement, and $950M in operating cash flow. https://seekingalpha.com/news/731711?source=tweet\" data-url=\"https://seekingalpha.com/news/731711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731591\" data-ts=\"1356038305\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731591\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nike (NYSE:NKE): FQ2 EPS of $1.14 beats by $0.14. Revenue of $6.0B (+7% Y/Y) beats by $0.01B....</a></h4><b>Nike (NYSE:<a href=\"https://seekingalpha.com/symbol/NKE\" title=\"Nike Inc.\">NKE</a>):</b> FQ2 EPS of $1.14 <font color=\"green\">beats by $0.14</font>. Revenue of $6.0B (+7% Y/Y) <font color=\"green\">beats by $0.01B</font>. Shares  <font color=\"green\">+2.7%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"731591\" data-linked=\"Nike (NYSE:NKE): FQ2 EPS of $1.14 beats by $0.14. Revenue of $6.0B (+7% Y/Y) beats by $0.01B....\" data-tweet=\"$NKE - Nike (NYSE:NKE): FQ2 EPS of $1.14 beats by $0.14. Revenue of $6.0B (+7% Y/Y) beats by $0.01B. Shares +2.7% premarket. (PR) https://seekingalpha.com/news/731591?source=tweet\" data-url=\"https://seekingalpha.com/news/731591\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731581\" data-ts=\"1356038172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research In Motion (RIMM): FQ3 EPS of -$0.22 beats by $0.13. Revenue of $2.73B (-47% Y/Y) beats...</a></h4><b>Research In Motion (RIMM):</b> FQ3 EPS of -$0.22 <font color=\"green\">beats by $0.13</font>. Revenue of $2.73B (-47% Y/Y) <font color=\"green\">beats by $70M</font>. 6.9M BlackBerrys shipped, 255K PlayBooks. BlackBerry subs fell by 1M Q/Q to 79M. Shares halted. (PR)<div class=\"tiny-share-widget\" data-id=\"731581\" data-linked=\"Research In Motion (RIMM): FQ3 EPS of -$0.22 beats by $0.13. Revenue of $2.73B (-47% Y/Y) beats...\" data-tweet=\"$BB - Research In Motion (RIMM): FQ3 EPS of -$0.22 beats by $0.13. Revenue of $2.73B (-47% Y/Y) beats by $70M. 6.9M BlackBerrys shipped, 255K PlayBooks. BlackBerry subs fell by 1M Q/Q to 79M. Shares halted. (PR) https://seekingalpha.com/news/731581?source=tweet\" data-url=\"https://seekingalpha.com/news/731581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731571\" data-ts=\"1356037991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731571\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron (NASDAQ:MU): Q3 EPS of -$0.27 misses by $0.07. Revenue of $2.0B in-line. Shares -3% AH. (PR)</a></h4><b>Micron (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>):</b> Q3 EPS of -$0.27 <font color=\"red\">misses by $0.07</font>. Revenue of $2.0B <font color=\"black\">in-line</font>. Shares  <font color=\"red\">-3%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"731571\" data-linked=\"Micron (NASDAQ:MU): Q3 EPS of -$0.27 misses by $0.07. Revenue of $2.0B in-line. Shares -3% AH. (PR)\" data-tweet=\"$MU - Micron (NASDAQ:MU): Q3 EPS of -$0.27 misses by $0.07. Revenue of $2.0B in-line. Shares -3% AH. (PR) https://seekingalpha.com/news/731571?source=tweet\" data-url=\"https://seekingalpha.com/news/731571\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731541\" data-ts=\"1356037593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat (NYSE:RHT): Q3 EPS of $0.29 in-line. Revenue of $344M (+18% Y/Y) beats by $6.43M. Shares...</a></h4><b>Red Hat (NYSE:<a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a>):</b> Q3 EPS of $0.29 in-line. Revenue of $344M (+18% Y/Y) <font color=\"green\">beats by $6.43M</font>. Shares  <font color=\"green\">+3.97%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"731541\" data-linked=\"Red Hat (NYSE:RHT): Q3 EPS of $0.29 in-line. Revenue of $344M (+18% Y/Y) beats by $6.43M. Shares...\" data-tweet=\"$RHT - Red Hat (NYSE:RHT): Q3 EPS of $0.29 in-line. Revenue of $344M (+18% Y/Y) beats by $6.43M. Shares +3.97% premarket. (PR) https://seekingalpha.com/news/731541?source=tweet\" data-url=\"https://seekingalpha.com/news/731541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731521\" data-ts=\"1356037488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRC\" target=\"_blank\">GPRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guanwei Recycling (GPRC +7.2%) finishes the day strong after the China-based manufacturer of...</a></h4><p>Guanwei Recycling (<a href=\"https://seekingalpha.com/symbol/GPRC\" title=\"Guanwei Recycling Corp.\">GPRC</a> <font color=\"green\">+7.2%</font>) finishes the day strong after the China-based manufacturer of recycled low density polyethylene announced that it has regained compliance with Nasdaq by maintaining a closing share price of at least $1 for 10 consecutive business days.</p><div class=\"tiny-share-widget\" data-id=\"731521\" data-linked=\"Guanwei Recycling (GPRC +7.2%) finishes the day strong after the China-based manufacturer of...\" data-tweet=\"$GPRC - Guanwei Recycling (GPRC +7.2%) finishes the day strong after the China-based manufacturer of recycled low density polyethylene announced that it has regained compliance with Nasdaq by maintaining a closing share price of at least $1 for 10 conse... https://seekingalpha.com/news/731521?source=tweet\" data-url=\"https://seekingalpha.com/news/731521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731461\" data-ts=\"1356035519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCO\" target=\"_blank\">MDCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink ups its price target for The Medicines Co. (MDCO +7.1%) to $34 from $30 on the back of...</a></h4><p>Leerink <a href=\"http://www.theflyonthewall.com/permalinks/entry.php/MDCOid1758910/MDCO-The-Medicines-Co-price-target-raised-to--from--at-Leerink\" target=\"_blank\">ups its price target</a> for The Medicines Co. (<a href=\"https://seekingalpha.com/symbol/MDCO\" title=\"The Medicines Company\">MDCO</a> <font color=\"green\">+7.1%</font>) to $34 from $30 on the  back of the drug developer's previously announced positive results for the Phase III trial of oritavancin. The firm now sees it as a takeout candidate and reiterates an Outperform. Separately, JPMorgan also <a href=\"http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+The+Medicines+Company+%28MDCO%29+to+Overweight/7963210.html\" target=\"_blank\">ups the shares</a> to Overweight.</p><div class=\"tiny-share-widget\" data-id=\"731461\" data-linked=\"Leerink ups its price target for The Medicines Co. (MDCO +7.1%) to $34 from $30 on the back of...\" data-tweet=\"$MDCO - Leerink ups its price target for The Medicines Co. (MDCO +7.1%) to $34 from $30 on the back of the drug developer&#39;s previously announced positive results for the Phase III trial of oritavancin. The firm now sees it as a takeout candidate and rei... https://seekingalpha.com/news/731461?source=tweet\" data-url=\"https://seekingalpha.com/news/731461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731451\" data-ts=\"1356035188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX (VHC -4.7%) is off a trading halt, with the company reporting a judge - in a post-trial...</a></h4><p>VirnetX (<a href=\"https://seekingalpha.com/symbol/VHC\" title=\"VirnetX Holding Corporation\">VHC</a> <font color=\"red\">-4.7%</font>) is off a trading halt, with the company reporting a judge - in a post-trial hearing - has ordered Apple (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AAPL\" title=\"Apple Inc.\">AAPL</a>) to provide updated sales data for certain products, including the iPhone 5 by mid-January. The company<a href=\"https://seekingalpha.com/currents/post/646121\" target=\"_blank\"> recently won</a> a $368.2M judgement against Apple for patent infringement. (PR)</p><div class=\"tiny-share-widget\" data-id=\"731451\" data-linked=\"VirnetX (VHC -4.7%) is off a trading halt, with the company reporting a judge - in a post-trial...\" data-tweet=\"$VHC $VHC $AAPL - VirnetX (VHC -4.7%) is off a trading halt, with the company reporting a judge - in a post-trial hearing - has ordered Apple (NASDAQ:AAPL) to provide updated sales data for certain products, including the iPhone 5 by mid-January. The co... https://seekingalpha.com/news/731451?source=tweet\" data-url=\"https://seekingalpha.com/news/731451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731421\" data-ts=\"1356034079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMN\" target=\"_blank\">EMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731421\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eastman Chemical (EMN +1.6%) is upgraded to Buy from Hold with a $75 price target at Gilford...</a></h4><p>Eastman Chemical (<a href=\"https://seekingalpha.com/symbol/EMN\" title=\"Eastman Chemical Co.\">EMN</a> <font color=\"green\">+1.6%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/12/12/3191482/update-gilford-securities-upgrades-eastman-chemical-to-b\" target=\"_blank\">upgraded to Buy</a> from Hold with a $75 price target at Gilford Securities, which believes EMN Eastman is \"poised to become the premier, most-favored holding in the chemical space, on the basis of both its businesses and its management credibility.\"</p><div class=\"tiny-share-widget\" data-id=\"731421\" data-linked=\"Eastman Chemical (EMN +1.6%) is upgraded to Buy from Hold with a $75 price target at Gilford...\" data-tweet=\"$EMN - Eastman Chemical (EMN +1.6%) is upgraded to Buy from Hold with a $75 price target at Gilford Securities, which believes EMN Eastman is &quot;poised to become the premier, most-favored holding in the chemical space, on the basis of both its businesses ... https://seekingalpha.com/news/731421?source=tweet\" data-url=\"https://seekingalpha.com/news/731421\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731301\" data-ts=\"1356030935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLIR\" target=\"_blank\">FLIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731301\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FLIR Systems (FLIR +2.7%) gets a boost today from an upgrade to Buy at Sterne Agee with a $30...</a></h4><p>FLIR Systems (<a href=\"https://seekingalpha.com/symbol/FLIR\" title=\"FLIR Systems, Inc.\">FLIR</a> <font color=\"green\">+2.7%</font>) gets a boost today from an <a href=\"http://www.streetinsider.com/Upgrades/Sterne+Agee+Upgrades+FLIR+Systems%2C+Inc.+%28FLIR%29+to+Buy/7962372.html\" target=\"_blank\">upgrade to Buy</a> at Sterne Agee with a $30 price target. The firm says that <a href=\"https://seekingalpha.com/symbol/FLIR\" title=\"FLIR Systems, Inc.\">FLIR</a> is back on the path to growth, and near term pressures stemming from both its commercial and government end markets provides an attractive entry point for long-term investors.</p><div class=\"tiny-share-widget\" data-id=\"731301\" data-linked=\"FLIR Systems (FLIR +2.7%) gets a boost today from an upgrade to Buy at Sterne Agee with a $30...\" data-tweet=\"$FLIR - FLIR Systems (FLIR +2.7%) gets a boost today from an upgrade to Buy at Sterne Agee with a $30 price target. The firm says that FLIR is back on the path to growth, and near term pressures stemming from both its commercial and government end marke... https://seekingalpha.com/news/731301?source=tweet\" data-url=\"https://seekingalpha.com/news/731301\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731231\" data-ts=\"1356027725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AWAY\" target=\"_blank\">AWAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HomeAway (AWAY +8.5%) is among the day&#39;s tech standouts after catching an upgrade to Overweight...</a></h4>HomeAway (<a href='https://seekingalpha.com/symbol/AWAY' title='HomeAway, Inc.'>AWAY</a> <font color=\"green\">+8.5%</font>) is among the day's tech standouts after catching an <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Barclays+Upgrades+HomeAway+%28AWAY%29+to+Overweight/7962417.html\">upgrade to Overweight</a> from Barclays. 28.5% of the vacation rental listings site's float was shorted as of Nov. 30.<div class=\"tiny-share-widget\" data-id=\"731231\" data-linked=\"HomeAway (AWAY +8.5%) is among the day&#39;s tech standouts after catching an upgrade to Overweight...\" data-tweet=\"$AWAY - HomeAway (AWAY +8.5%) is among the day&#39;s tech standouts after catching an upgrade to Overweight from Barclays. 28.5% of the vacation rental listings site&#39;s float was shorted as of Nov. 30. https://seekingalpha.com/news/731231?source=tweet\" data-url=\"https://seekingalpha.com/news/731231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731151\" data-ts=\"1356025846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731151\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pershing Square&#39;s Bill Ackman gives his presentation on Herbalife (HLF -4.2%) this morning, and...</a></h4><p>Pershing Square's Bill Ackman gives his presentation on Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-4.2%</font>) this morning, and <em>Barron's</em> Brandon Conway was there to take notes. Ackman kicks it all off by saying he is in fact short the stock, but refutes the accusation that he's pushing the shares down because he owns puts due to expire at the end of the week. He focuses instead on what he sees as <a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a>'s questionable R&amp;D, phony reliance on PhD credentials, and flashy sales promotions as demonstrable proof of the classic pyramid scheme. Take a look: <a href=\"http://blogs.barrons.com/focusonfunds/2012/12/20/ackman-have-you-ever-bought-an-herbalife-product/?mod=BOL_hps_blog_fof\" target=\"_blank\">Barron's HLF presentation notes</a>.</p><div class=\"tiny-share-widget\" data-id=\"731151\" data-linked=\"Pershing Square&#39;s Bill Ackman gives his presentation on Herbalife (HLF -4.2%) this morning, and...\" data-tweet=\"$HLF - Pershing Square&#39;s Bill Ackman gives his presentation on Herbalife (HLF -4.2%) this morning, and Barron&#39;s Brandon Conway was there to take notes. Ackman kicks it all off by saying he is in fact short the stock, but refutes the accusation that he&#39;s... https://seekingalpha.com/news/731151?source=tweet\" data-url=\"https://seekingalpha.com/news/731151\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731131\" data-ts=\"1356025540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROMA\" target=\"_blank\">ROMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: ROMA +65%. ACFC +51%. NYX +33%. AMPL +37%. ELOQ +31%. SINO +22%. BNSO...</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/ROMA' title='Roma Financial Corporation'>ROMA</a> <font color=\"green\">+65%</font>. <a href='https://seekingalpha.com/symbol/ACFC' title='Atlantic Coast Federal Corporation'>ACFC</a> <font color=\"green\">+51%</font>. <a href='https://seekingalpha.com/symbol/NYX' title='NYSE Euronext'>NYX</a> <font color=\"green\">+33%</font>. <a href='https://seekingalpha.com/symbol/AMPL' title='Ampal - American Israel Corporation'>AMPL</a> <font color=\"green\">+37%</font>. <a href='https://seekingalpha.com/symbol/ELOQ' title='Eloqua'>ELOQ</a> <font color=\"green\">+31%</font>. <a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a> <font color=\"green\">+22%</font>. <a href='https://seekingalpha.com/symbol/BNSO' title='Bonso Electronics International, Inc.'>BNSO</a> <font color=\"green\">+21%</font>. <a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a> <font color=\"green\">+22%</font>. <a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color=\"green\">+14%</font>. <a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color=\"green\">+16%</font>. <br /><b>Midday top 10 Losers:</b> <a href='https://seekingalpha.com/symbol/CCU' title='Compania Cervecerias Unidas S.A.'>CCU</a> <font color=\"red\">-60%</font>. <a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a> <font color=\"red\">-45%</font>. <a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a> <font color=\"red\">-19%</font>. <a href='https://seekingalpha.com/symbol/MDRX' title='Allscripts Healthcare Solutions, Inc.'>MDRX</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/UNXL' title='Uni-Pixel, Inc.'>UNXL</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/GBX' title='The Greenbrier Companies, Inc.'>GBX</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/QUAD' title='Quad/Graphics, Inc.'>QUAD</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/ARII' title='American Railcar Industries, Inc.'>ARII</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/PTEK' title='PokerTek, Inc.'>PTEK</a> <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color=\"red\">-10%</font>.<div class=\"tiny-share-widget\" data-id=\"731131\" data-linked=\"Midday top 10 gainers: ROMA +65%. ACFC +51%. NYX +33%. AMPL +37%. ELOQ +31%. SINO +22%. BNSO...\" data-tweet=\"$ROMA $ROMA $ACFC - Midday top 10 gainers: ROMA +65%. ACFC +51%. NYX +33%. AMPL +37%. ELOQ +31%. SINO +22%. BNSO +21%. DYNT +22%. SQNS +14%. RAD +16%. Midday top 10 Losers: CCU -60%. FOLD -45%. BOSC -19%. MDRX -13%. UNXL -13%. GBX -11%. QUAD -11%. ARII ... https://seekingalpha.com/news/731131?source=tweet\" data-url=\"https://seekingalpha.com/news/731131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731101\" data-ts=\"1356024740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mellanox (MLNX -6.7%) gives back yesterday&#39;s Oracle-fueled gains after Israel&#39;s Globes reports...</a></h4><p>Mellanox (<a href=\"https://seekingalpha.com/symbol/MLNX\" title=\"Mellanox Technologies, Ltd.\">MLNX</a> <font color=\"red\">-6.7%</font>) gives back yesterday's <a href=\"https://seekingalpha.com/currents/post/728441\" target=\"_blank\">Oracle-fueled gains</a> after Israel's <em>Globes</em> reports of <a href=\"http://www.globes.co.il/serveen/globes/docview.asp?did=1000808182\" target=\"_blank\">heavy institutional selling</a>, something its sources attribute to expectations Q4 and perhaps Q1 results will miss expectations. The paper notes short interest has soared, and suggests a <a href=\"https://seekingalpha.com/currents/post/530181\" target=\"_blank\">CFO change</a> and \"conservative\" commentary at presentations has institutions on edge. Shares have already been crushed thanks to <a href=\"https://seekingalpha.com/currents/post/592531\" target=\"_blank\">soft Q4 guidance</a>. Barclays remains bullish, <a href=\"http://blogs.barrons.com/techtraderdaily/2012/12/19/mlnx-barclays-pounds-table-on-oracle-biz-after-purely-technical-decline/?mod=yahoobarrons\" target=\"_blank\">arguing</a> demand for low-latency, high-speed, data center connectivity will continue driving growth. (<a href=\"https://seekingalpha.com/article/856071-mellanox-end-of-romley-upgrade-signals-steep-downside\" target=\"_blank\">Kerrisdale Capital</a>)</p><div class=\"tiny-share-widget\" data-id=\"731101\" data-linked=\"Mellanox (MLNX -6.7%) gives back yesterday&#39;s Oracle-fueled gains after Israel&#39;s Globes reports...\" data-tweet=\"$MLNX - Mellanox (MLNX -6.7%) gives back yesterday&#39;s Oracle-fueled gains after Israel&#39;s Globes reports of heavy institutional selling, something its sources attribute to expectations Q4 and perhaps Q1 results will miss expectations. The paper notes shor... https://seekingalpha.com/news/731101?source=tweet\" data-url=\"https://seekingalpha.com/news/731101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731091\" data-ts=\"1356024716\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HERO\" target=\"_blank\">HERO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731091\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hercules Offshore&#39;s (HERO +4.6%) share price target is raised to $7.50 from $6.50 at Dahlman...</a></h4><p>Hercules Offshore's (<a href=\"https://seekingalpha.com/symbol/HERO\" title=\"Hercules Offshore Inc\">HERO</a> <font color=\"green\">+4.6%</font>) share price target is <a href=\"http://www.jagsreport.com/2012/12/equities-research-analysts-price-target-changes-for-december-20th-aht-bax-bbby-bmr-bxp-cab-cog-cuz-cvs-ddd/\" target=\"_blank\">raised</a> to $7.50 from $6.50 at Dahlman Rose, as the firm increases its 2013 EPS estimate to $0.50 from $0.35 (consensus $0.27) and its adjusted EBITDA estimate 9% to $351M due to higher leading-edge fixtures following yesterday's <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=192573&amp;p=irol-reportsOther\" target=\"_blank\">fleet status report</a>.</p><div class=\"tiny-share-widget\" data-id=\"731091\" data-linked=\"Hercules Offshore&#39;s (HERO +4.6%) share price target is raised to $7.50 from $6.50 at Dahlman...\" data-tweet=\"$HERO $HEROQ - Hercules Offshore&#39;s (HERO +4.6%) share price target is raised to $7.50 from $6.50 at Dahlman Rose, as the firm increases its 2013 EPS estimate to $0.50 from $0.35 (consensus $0.27) and its adjusted EBITDA estimate 9% to $351M due to highe... https://seekingalpha.com/news/731091?source=tweet\" data-url=\"https://seekingalpha.com/news/731091\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731081\" data-ts=\"1356024358\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIIB\" target=\"_blank\">BIIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biogen Idec (BIIB -0.2%) says it&#39;s collaborating with several leading academic research centers...</a></h4><p>Biogen Idec (<a href=\"https://seekingalpha.com/symbol/BIIB\" title=\"Biogen Inc.\">BIIB</a> <font color=\"red\">-0.2%</font>) says it's collaborating with several leading academic research centers to leverage a range of scientific techniques and disciplines to identify new approaches to treating amyotrophic lateral sclerosis. It is anticipated that coordinating research and sharing results across a number of different disciplines will greatly accelerate the understanding of the mechanisms of the disease and the development of new treatments.</p><div class=\"tiny-share-widget\" data-id=\"731081\" data-linked=\"Biogen Idec (BIIB -0.2%) says it&#39;s collaborating with several leading academic research centers...\" data-tweet=\"$BIIB - Biogen Idec (BIIB -0.2%) says it&#39;s collaborating with several leading academic research centers to leverage a range of scientific techniques and disciplines to identify new approaches to treating amyotrophic lateral sclerosis. It is anticipated ... https://seekingalpha.com/news/731081?source=tweet\" data-url=\"https://seekingalpha.com/news/731081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"731001\" data-ts=\"1356022270\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRAN\" target=\"_blank\">PRAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/731001\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prana Biotechnology (PRAN +3.2%) moves up after being initiated at Burrill Institutional...</a></h4><p>Prana Biotechnology (<a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+3.2%</font>) moves up after <a target=\"_blank\" href=\"http://www.streetinsider.com/New+Coverage/Burrill+Starts+Prana+Biotechnology+%28PRAN%29+at+Market+Outperform/7962794.html\">being initiated</a> at Burrill Institutional Research with an Outperform and a price target of $5 a share. Burrill cites the company's progress in developing technology for the treatment of neurodegenerative disorders. Yesterday <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> announced that it's <a target=\"_blank\" href=\"http://www.streetinsider.com/Press+Releases/Prana+Completes+Recruitment+in+Huntington+Trial/7959444.html\">completed recruitment</a> in its Phase IIa clinical trial using its experimental drug PBT2 for the treatment of patients with Huntington Disease.</p><div class=\"tiny-share-widget\" data-id=\"731001\" data-linked=\"Prana Biotechnology (PRAN +3.2%) moves up after being initiated at Burrill Institutional...\" data-tweet=\"$PRAN $ATHE - Prana Biotechnology (PRAN +3.2%) moves up after being initiated at Burrill Institutional Research with an Outperform and a price target of $5 a share. Burrill cites the company&#39;s progress in developing technology for the treatment of neuro... https://seekingalpha.com/news/731001?source=tweet\" data-url=\"https://seekingalpha.com/news/731001\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730951\" data-ts=\"1356020672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CME\" target=\"_blank\">CME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">It took the market a few minutes to figure it out, but the ICE/NYSE deal puts a bulls eye on the...</a></h4>It took the market a few minutes to figure it out, but the ICE/NYSE deal <a href=\"http://www.suntimes.com/business/17133483-420/intercontinentalexchange-targets-cme-with-huge-nyse-deal.html\" target=\"_blank\">puts a bulls eye </a>on the back of the <a href='https://seekingalpha.com/symbol/CME' title='CME Group Inc.'>CME</a>, now <font color=\"red\">-3%</font>. NYSE has tried and failed to challenge the Chicago derivatives operator, but ICE - which built a serious competitor to CME in what seems like the blink of an eye - <a href=\"https://seekingalpha.com/currents/post/730361\" target=\"_blank\">has expertise</a> the Big Board doesn't have. <a href='https://seekingalpha.com/symbol/ICE' title='Intercontinental Exchange, Inc.'>ICE</a> <font color=\"red\">-2.6%</font>, <a href='https://seekingalpha.com/symbol/NYX' title='NYSE Euronext'>NYX</a> <font color=\"green\">+31.5%</font>.<div class=\"tiny-share-widget\" data-id=\"730951\" data-linked=\"It took the market a few minutes to figure it out, but the ICE/NYSE deal puts a bulls eye on the...\" data-tweet=\"$CME $CME $ICE - It took the market a few minutes to figure it out, but the ICE/NYSE deal puts a bulls eye on the back of the CME, now -3%. NYSE has tried and failed to challenge the Chicago derivatives operator, but ICE - which built a serious competit... https://seekingalpha.com/news/730951?source=tweet\" data-url=\"https://seekingalpha.com/news/730951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730941\" data-ts=\"1356020499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD (AMD -4.2%) is slumping, and Intel (INTC -0.5%) and Nvidia (NVDA -0.6%) are slightly off,...</a></h4><p>AMD (<a href=\"https://seekingalpha.com/symbol/AMD\" title=\"Advanced Micro Devices, Inc.\">AMD</a> <font color=\"red\">-4.2%</font>) is slumping, and Intel (<a href=\"https://seekingalpha.com/symbol/INTC\" title=\"Intel Corporation\">INTC</a> <font color=\"red\">-0.5%</font>) and Nvidia (<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a> <font color=\"red\">-0.6%</font>) are slightly off, after Evercore's Patrick Wang <a target=\"_blank\" href=\"http://www.forbes.com/sites/ericsavitz/2012/12/20/intel-amd-nvidia-evercore-slices-ests-on-soft-pc-sales/?utm_source=twitterfeed&amp;utm_medium=twitter\">joins the estimate-cutting parade</a>, and co-worker Rob Cihra offers mixed commentary about PC demand. While holding out hope Windows 8 and China will lead demand to stabilize in 1H, Cihra notes many industry suppliers appear to have under-shipped end-user sales (which themselves <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/580141\">aren't great</a>) in Q4 thanks to <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/724481\">inventory drawdowns</a>. \"Early ultrabooks have been stymied by high prices and Win8 so far looks like a remarkable non-factor.,\" he adds.</p><div class=\"tiny-share-widget\" data-id=\"730941\" data-linked=\"AMD (AMD -4.2%) is slumping, and Intel (INTC -0.5%) and Nvidia (NVDA -0.6%) are slightly off,...\" data-tweet=\"$AMD $AMD $INTC - AMD (AMD -4.2%) is slumping, and Intel (INTC -0.5%) and Nvidia (NVDA -0.6%) are slightly off, after Evercore&#39;s Patrick Wang joins the estimate-cutting parade, and co-worker Rob Cihra offers mixed commentary about PC demand. While holdi... https://seekingalpha.com/news/730941?source=tweet\" data-url=\"https://seekingalpha.com/news/730941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730931\" data-ts=\"1356020392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDRX\" target=\"_blank\">MDRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leerink says there&#39;s potentially still a chance of an eventual sale of Allscripts (MDRX -16%),...</a></h4><p>Leerink says there's potentially <a target=\"_blank\" href=\"http://wallstcheatsheet.com/stocks/herbalife-remains-under-pressure-and-3-must-see-stock-analyses.html/\">still a chance</a> of an eventual sale of Allscripts (<a href=\"https://seekingalpha.com/symbol/MDRX\" title=\"Allscripts Healthcare Solutions, Inc.\">MDRX</a> <font color=\"red\">-16%</font>), despite yesterday's statement by the company regarding the conclusion of its strategic review process and decision not to put itself up for sale. It probably won't occur in the near term, however, so consequently the firm predicts the stock will continue to face significant pressure. It reduces its target range to $8 - $9 from $12 - $14.</p><div class=\"tiny-share-widget\" data-id=\"730931\" data-linked=\"Leerink says there&#39;s potentially still a chance of an eventual sale of Allscripts (MDRX -16%),...\" data-tweet=\"$MDRX - Leerink says there&#39;s potentially still a chance of an eventual sale of Allscripts (MDRX -16%), despite yesterday&#39;s statement by the company regarding the conclusion of its strategic review process and decision not to put itself up for sale. It p... https://seekingalpha.com/news/730931?source=tweet\" data-url=\"https://seekingalpha.com/news/730931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730891\" data-ts=\"1356019326\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730891\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene (TROV +8%) gets a pop today after granting Novartis (NYSE:NVS) subsidiary Genoptix...</a></h4><p>Trovagene (<a href=\"https://seekingalpha.com/symbol/TROV\" title=\"TrovaGene, Inc.\">TROV</a> <font color=\"green\">+8%</font>) gets a pop today after granting Novartis (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>) subsidiary Genoptix licensing rights to incorporate its nucleophosmin protein, NPM1, into research and clinical testing services for acute myelogenous leukemia.  Trovagene holds an exclusive patent on the protein. Terms of the agreement include upfront fees and royalty payments. Additional financial terms were not disclosed. Additionally, Roth Capital <a href=\"http://www.streetinsider.com/New+Coverage/Roth+Capital+Starts+TrovaGene+%28TROV%29+at+Buy/7962431.html\" target=\"_blank\">initiates the shares</a> with a Buy and a price target of $11 a share.</p><div class=\"tiny-share-widget\" data-id=\"730891\" data-linked=\"Trovagene (TROV +8%) gets a pop today after granting Novartis (NYSE:NVS) subsidiary Genoptix...\" data-tweet=\"$TROV $TROV $NVS - Trovagene (TROV +8%) gets a pop today after granting Novartis (NYSE:NVS) subsidiary Genoptix licensing rights to incorporate its nucleophosmin protein, NPM1, into research and clinical testing services for acute myelogenous leukemia. ... https://seekingalpha.com/news/730891?source=tweet\" data-url=\"https://seekingalpha.com/news/730891\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730871\" data-ts=\"1356019054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCZ\" target=\"_blank\">OCZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730871\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OCZ Technology (OCZ +4.2%) rallies some more after announcing it has received an extension to...</a></h4><p>OCZ Technology (<a href=\"https://seekingalpha.com/symbol/OCZ\" title=\"OCZ Technology Group Inc\">OCZ</a> <font color=\"green\">+4.2%</font>) rallies some more after announcing it has received an extension to regain NASDAQ listing compliance, after being granted an exception related to its delayed Aug. quarter 10-Q filing. OCZ still has to file the 10-Q, and all other delinquent reports, by Feb. 28. Shares are now <font color=\"green\">up 80%</font> from their Nov. 23 low. (PR) (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/723771\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"730871\" data-linked=\"OCZ Technology (OCZ +4.2%) rallies some more after announcing it has received an extension to...\" data-tweet=\"$OCZ - OCZ Technology (OCZ +4.2%) rallies some more after announcing it has received an extension to regain NASDAQ listing compliance, after being granted an exception related to its delayed Aug. quarter 10-Q filing. OCZ still has to file the 10-Q, and ... https://seekingalpha.com/news/730871?source=tweet\" data-url=\"https://seekingalpha.com/news/730871\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730851\" data-ts=\"1356018398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFS\" target=\"_blank\">DFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Discover (DFS -3%) FQ4 earnings: Bulls on the high-flier (+61% YTD) may have a buying...</a></h4><p>More on Discover (<a href=\"https://seekingalpha.com/symbol/DFS\" title=\"Discover Financial Services\">DFS</a> <font color=\"red\">-3%</font>) FQ4 <a href=\"https://seekingalpha.com/currents/post/730321\" target=\"_blank\">earnings</a>: Bulls on the high-flier (+61% YTD) may have a buying opportunity as the earnings miss looks to be the result of an 18% increase in expenses thanks to costs associated with the Tree.com acquisition and new partnerships. Operationally: Total loans +6% Y/Y, net interest margin +34 bps, net charge-offs a historical low of 2.29%, delinquency rate of 1.86% down 53 bps. (PR)</p><div class=\"tiny-share-widget\" data-id=\"730851\" data-linked=\"More on Discover (DFS -3%) FQ4 earnings: Bulls on the high-flier (+61% YTD) may have a buying...\" data-tweet=\"$DFS - More on Discover (DFS -3%) FQ4 earnings: Bulls on the high-flier (+61% YTD) may have a buying opportunity as the earnings miss looks to be the result of an 18% increase in expenses thanks to costs associated with the Tree.com acquisition and new ... https://seekingalpha.com/news/730851?source=tweet\" data-url=\"https://seekingalpha.com/news/730851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730831\" data-ts=\"1356018068\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLF\" target=\"_blank\">HLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730831\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA Merrill Lynch comes to the defense of Herbalife (HLF -5%) this morning, saying there&#39;s no...</a></h4><p>BofA Merrill Lynch <a target=\"_blank\" href=\"http://wallstcheatsheet.com/stocks/herbalife-remains-under-pressure-and-3-must-see-stock-analyses.html/\">comes to the defense</a> of Herbalife (<a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> <font color=\"red\">-5%</font>) this morning, saying there's no evidence to validate the accusation that the company's a <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/728941\">pyramid scheme</a>. The firm notes that <a href=\"https://seekingalpha.com/symbol/HLF\" title=\"Herbalife Ltd.\">HLF</a> has one of the strongest balance sheets in the group, with the potential to drive $1 per share in EPS accretion if it were to fully exercise its $1B buyback. The stock may be pressured over the near-term until this blows over, but Merrill reiterates a Buy with a $65 target.</p><div class=\"tiny-share-widget\" data-id=\"730831\" data-linked=\"BofA Merrill Lynch comes to the defense of Herbalife (HLF -5%) this morning, saying there&#39;s no...\" data-tweet=\"$HLF - BofA Merrill Lynch comes to the defense of Herbalife (HLF -5%) this morning, saying there&#39;s no evidence to validate the accusation that the company&#39;s a pyramid scheme. The firm notes that HLF has one of the strongest balance sheets in the group, ... https://seekingalpha.com/news/730831?source=tweet\" data-url=\"https://seekingalpha.com/news/730831\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730801\" data-ts=\"1356017360\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRS\" target=\"_blank\">ARRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730801\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arris (ARRS +5.5%) is well off the AH highs it saw on news it&#39;s buying Motorola&#39;s...</a></h4><p>Arris (<a href=\"https://seekingalpha.com/symbol/ARRS\" title=\"ARRIS International plc\">ARRS</a> <font color=\"green\">+5.5%</font>) is well off the AH highs it saw on news it's buying Motorola's pay-TV/broadband hardware unit from Google, but is still posting a decent gain. With the combined company sporting 500 customers in 70 countries, the deal will go a long way towards helping Arris diversify: right now, it gets <a href=\"http://www.dailyherald.com/article/20121220/business/712209950/\" target=\"_blank\">about half its sales</a> from Comcast and Time Warner. (previous: <a href=\"https://seekingalpha.com/currents/post/729531\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/729681\" target=\"_blank\">II</a>)</p><div class=\"tiny-share-widget\" data-id=\"730801\" data-linked=\"Arris (ARRS +5.5%) is well off the AH highs it saw on news it&#39;s buying Motorola&#39;s...\" data-tweet=\"$ARRS - Arris (ARRS +5.5%) is well off the AH highs it saw on news it&#39;s buying Motorola&#39;s pay-TV/broadband hardware unit from Google, but is still posting a decent gain. With the combined company sporting 500 customers in 70 countries, the deal will go ... https://seekingalpha.com/news/730801?source=tweet\" data-url=\"https://seekingalpha.com/news/730801\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730771\" data-ts=\"1356017086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SD\" target=\"_blank\">SD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730771\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SandRidge Energy (SD -5.3%) is cut to Hold from Buy at KeyBanc after striking a deal to sell its...</a></h4><p>SandRidge Energy (<a href=\"https://seekingalpha.com/symbol/SD\" title=\"SandRidge Energy, Inc.\">SD</a> <font color=\"red\">-5.3%</font>) is <a href=\"http://www.streetinsider.com/Downgrades/KeyBanc+Downgrades+SandRidge+Energy+%28SD%29+to+Hold/7962669.html\" target=\"_blank\">cut to Hold</a> from Buy at KeyBanc after <a href=\"https://seekingalpha.com/currents/post/729181\" target=\"_blank\">striking a deal</a> to sell its Permian Basin assets for $2.6B. Though the deal essentially prefunds its Mississippian development for the next few years, the firm believes the ultimate returns and oil/liquids mix of the Mississippian remains an  open question and generally is inferior to Permian returns.</p><div class=\"tiny-share-widget\" data-id=\"730771\" data-linked=\"SandRidge Energy (SD -5.3%) is cut to Hold from Buy at KeyBanc after striking a deal to sell its...\" data-tweet=\"$SD - SandRidge Energy (SD -5.3%) is cut to Hold from Buy at KeyBanc after striking a deal to sell its Permian Basin assets for $2.6B. Though the deal essentially prefunds its Mississippian development for the next few years, the firm believes the ultim... https://seekingalpha.com/news/730771?source=tweet\" data-url=\"https://seekingalpha.com/news/730771\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730761\" data-ts=\"1356017028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730761\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS +4%) moves up this morning after it announced that Express Scripts (ESRX +0.2%) has...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+4%</font>) moves up this morning after it announced that Express Scripts (<a href=\"https://seekingalpha.com/symbol/ESRX\" title=\"Express Scripts, Inc.\">ESRX</a> <font color=\"green\">+0.2%</font>) has added its weight-loss drug Qsymia to its national pharmacy formularies. The drug has been added as a standard benefit option in a tier-3 position with a prior authorization. Under the plan, participating patients will now pay around $50 to $60 for their co-payment for a monthly prescription, which equates to approximately one-third of the retail price.</p><div class=\"tiny-share-widget\" data-id=\"730761\" data-linked=\"Vivus (VVUS +4%) moves up this morning after it announced that Express Scripts (ESRX +0.2%) has...\" data-tweet=\"$VVUS $VVUS $ESRX - Vivus (VVUS +4%) moves up this morning after it announced that Express Scripts (ESRX +0.2%) has added its weight-loss drug Qsymia to its national pharmacy formularies. The drug has been added as a standard benefit option in a tier-3 ... https://seekingalpha.com/news/730761?source=tweet\" data-url=\"https://seekingalpha.com/news/730761\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730741\" data-ts=\"1356016390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET-OLD\" target=\"_blank\">ET-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExactTarget (ET-OLD +4.5%) is rallying on news of Oracle&#39;s (ORCL +0.3%) deal to acquire cloud...</a></h4><p>ExactTarget (<a href=\"https://seekingalpha.com/symbol/ET-OLD\" title=\"Energy Transfer LP\">ET-OLD</a> <font color=\"green\">+4.5%</font>) is rallying on news of Oracle's (<a href=\"https://seekingalpha.com/symbol/ORCL\" title=\"Oracle Corporation\">ORCL</a> <font color=\"green\">+0.3%</font>) <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/730191\">deal to acquire </a>cloud marketing rival Eloqua (<a href=\"https://seekingalpha.com/symbol/ELOQ\" title=\"Eloqua\">ELOQ</a> <font color=\"green\">+31.1%</font>). Oracle's purchase comes a few months after it snapped up social media marketing plays <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/332111\">Vitrue</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/351711\">Collective Intellect</a>, and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/408261\">Involver</a>. The purchase could allow Oracle to offer a more comprehensive marketing solution (for now, anyway) than Salesforce.com (NYSE:<a href=\"https://seekingalpha.com/symbol/CRM\" title=\"Salesforce.com, Inc.\">CRM</a>), which (relying on <a href=\"https://seekingalpha.com/currents/post/341011\" target=\"_blank\">Buddy Media</a>) recently launched its social media-focused Marketing Cloud suite. GigaOm notes Eloqua has <a target=\"_blank\" href=\"http://gigaom.com/cloud/oracle-beefs-up-marketing-applications-savvy-with-871m-buy-of-eloqua/\">1,200 customers</a> for Oracle to cross-sell to.</p><div class=\"tiny-share-widget\" data-id=\"730741\" data-linked=\"ExactTarget (ET-OLD +4.5%) is rallying on news of Oracle&#39;s (ORCL +0.3%) deal to acquire cloud...\" data-tweet=\"$ET-OLD $ET-OLD $ORCL - ExactTarget (ET-OLD +4.5%) is rallying on news of Oracle&#39;s (ORCL +0.3%) deal to acquire cloud marketing rival Eloqua (ELOQ +31.1%). Oracle&#39;s purchase comes a few months after it snapped up social media marketing plays Vitrue, Col... https://seekingalpha.com/news/730741?source=tweet\" data-url=\"https://seekingalpha.com/news/730741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730711\" data-ts=\"1356016212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland Research downgrades Target (TGT -1.8%) to Neutral from Buy on valuation concerns and...</a></h4>Cleveland Research <a href=\"http://www.minyanville.com/trading-and-investing/stocks/articles/Stock-Downgrades253A-Research-In-Motion-Rolling/12/20/2012/id/46848\" target=\"_blank\">downgrades</a> Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-1.8%</font>) to Neutral from Buy on valuation concerns  and in light of the firm's channel checks showing the retailer is seeing sluggish December sales trends.<div class=\"tiny-share-widget\" data-id=\"730711\" data-linked=\"Cleveland Research downgrades Target (TGT -1.8%) to Neutral from Buy on valuation concerns and...\" data-tweet=\"$TGT - Cleveland Research downgrades Target (TGT -1.8%) to Neutral from Buy on valuation concerns and in light of the firm&#39;s channel checks showing the retailer is seeing sluggish December sales trends. https://seekingalpha.com/news/730711?source=tweet\" data-url=\"https://seekingalpha.com/news/730711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730641\" data-ts=\"1356015139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/END\" target=\"_blank\">END</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Endeavour International (END +2.6%) open higher after Steelhead Partners disclosed an...</a></h4><p>Shares of Endeavour International (<a href=\"https://seekingalpha.com/symbol/END\" title=\"Endeavour International Corporation\">END</a> <font color=\"green\">+2.6%</font>) open higher after Steelhead Partners disclosed an 11.7% stake via a <a href=\"http://www.sec.gov/Archives/edgar/data/1112412/000092189512002344/sc13d00322end_12182012.htm\" target=\"_blank\">13D filing</a> out last night. The hedge fund says it intends to engage in discussions with  END concerning actions that might \"improve corporate governance and unlock value for shareholders, including a thorough evaluation of all strategic alternatives.\"</p><div class=\"tiny-share-widget\" data-id=\"730641\" data-linked=\"Shares of Endeavour International (END +2.6%) open higher after Steelhead Partners disclosed an...\" data-tweet=\"$END - Shares of Endeavour International (END +2.6%) open higher after Steelhead Partners disclosed an 11.7% stake via a 13D filing out last night. The hedge fund says it intends to engage in discussions with END concerning actions that might &quot;improve c... https://seekingalpha.com/news/730641?source=tweet\" data-url=\"https://seekingalpha.com/news/730641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730621\" data-ts=\"1356015031\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of J.C. Penney (JCP -4.1%) slip lower as investors seem edgy with the Ira Sohn conference...</a></h4>Shares of J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-4.1%</font>) slip lower as investors seem edgy with the <a href=\"http://www.sohnconference.com/\" target=\"_blank\">Ira Sohn conference</a> in full swing in New York City. The combination of Bill Ackman and a live microphone has some traders heading to the sidelines.<div class=\"tiny-share-widget\" data-id=\"730621\" data-linked=\"Shares of J.C. Penney (JCP -4.1%) slip lower as investors seem edgy with the Ira Sohn conference...\" data-tweet=\"$JCP - Shares of J.C. Penney (JCP -4.1%) slip lower as investors seem edgy with the Ira Sohn conference in full swing in New York City. The combination of Bill Ackman and a live microphone has some traders heading to the sidelines. https://seekingalpha.com/news/730621?source=tweet\" data-url=\"https://seekingalpha.com/news/730621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730551\" data-ts=\"1356013330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCL\" target=\"_blank\">CCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730551\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carnival (NYSE:CCL): FQ4 EPS of $0.13 beats by $0.01. Revenue of $3.6B beats by $0.06B. Shares...</a></h4><b>Carnival (NYSE:<a href=\"https://seekingalpha.com/symbol/CCL\" title=\"Carnival Corporation\">CCL</a>):</b> FQ4 EPS of $0.13 <font color=\"green\">beats by $0.01</font>. Revenue of $3.6B <font color=\"green\">beats by $0.06B</font>. Shares  <font color=\"red\">-2.6%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"730551\" data-linked=\"Carnival (NYSE:CCL): FQ4 EPS of $0.13 beats by $0.01. Revenue of $3.6B beats by $0.06B. Shares...\" data-tweet=\"$CCL - Carnival (NYSE:CCL): FQ4 EPS of $0.13 beats by $0.01. Revenue of $3.6B beats by $0.06B. Shares -2.6% premarket. (PR) https://seekingalpha.com/news/730551?source=tweet\" data-url=\"https://seekingalpha.com/news/730551\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730521\" data-ts=\"1356012901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730521\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: U.S. stock futures are oscillating around zero following a data dump earlier and...</a></h4><b>Market preview:</b> U.S. stock futures are <a href=\"http://www.reuters.com/article/2012/12/20/markets-usa-stocks-idUSL1E8NK18I20121220\" target=\"_blank\">oscillating</a> around zero following a data dump earlier and as the talks over the fiscal cliff hit the latest bump. The S&amp;P benchmark is <font color=\"red\">-0.1%</font>, while European shares are green in choppy trading. NYSE <font color=\"green\">soars 42%</font> on ICE's <a href=\"https://seekingalpha.com/currents/post/730311\" target=\"_blank\">generous acquisition offer</a>, while Illumina is <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/currents/post/729931\" target=\"_blank\">speculation</a> it might be sold to Roche. <a href=\"https://seekingalpha.com/currents/post/729341\" target=\"_blank\">Later</a>: Existing Home Sales, Philly Fed Business Outlook, RIM and Nike earnings<div class=\"tiny-share-widget\" data-id=\"730521\" data-linked=\"Market preview: U.S. stock futures are oscillating around zero following a data dump earlier and...\" data-tweet=\"Market preview: U.S. stock futures are oscillating around zero following a data dump earlier and as the talks over the fiscal cliff hit the latest bump. The S&amp;P benchmark is -0.1%, while European shares are green in choppy trading. NYSE soars 42% on ICE... https://seekingalpha.com/news/730521?source=tweet\" data-url=\"https://seekingalpha.com/news/730521\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730491\" data-ts=\"1356012635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROMA\" target=\"_blank\">ROMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: ROMA +57%. NYX +40%. ELOQ +30%. RAD +16%. ILMN +9%. VVUS +8%. NDAQ +7%. ARRS...</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/ROMA\" title=\"Roma Financial Corporation\">ROMA</a> <font color=\"green\">+57%</font>. <a href=\"https://seekingalpha.com/symbol/NYX\" title=\"NYSE Euronext\">NYX</a> <font color=\"green\">+40%</font>. <a href=\"https://seekingalpha.com/symbol/ELOQ\" title=\"Eloqua\">ELOQ</a> <font color=\"green\">+30%</font>. <a href=\"https://seekingalpha.com/symbol/RAD\" title=\"Rite Aid Corporation\">RAD</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/ILMN\" title=\"Illumina, Inc.\">ILMN</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/NDAQ\" title=\"Nasdaq Inc.\">NDAQ</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/ARRS\" title=\"ARRIS International plc\">ARRS</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/ICE\" title=\"Intercontinental Exchange, Inc.\">ICE</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/JBL\" title=\"Jabil Inc.\">JBL</a> <font color=\"green\">+5%</font>. <br><b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/FOLD\" title=\"Amicus Therapeutics, Inc.\">FOLD</a> <font color=\"red\">-44%</font>. <a href=\"https://seekingalpha.com/symbol/MDRX\" title=\"Allscripts Healthcare Solutions, Inc.\">MDRX</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/OSIR\" title=\"Osiris Therapeutics, Inc.\">OSIR</a> <font color=\"red\">-10%</font>. NBG <font color=\"red\">-5%</font>. <a href=\"https://seekingalpha.com/symbol/BBBY\" title=\"Bed Bath &amp; Beyond Inc.\">BBBY</a> <font color=\"red\">-5%</font>.<div class=\"tiny-share-widget\" data-id=\"730491\" data-linked=\"Premarket gainers: ROMA +57%. NYX +40%. ELOQ +30%. RAD +16%. ILMN +9%. VVUS +8%. NDAQ +7%. ARRS...\" data-tweet=\"$ROMA $ROMA $NYX - Premarket gainers: ROMA +57%. NYX +40%. ELOQ +30%. RAD +16%. ILMN +9%. VVUS +8%. NDAQ +7%. ARRS +6%. ICE +6%. JBL +5%. Losers: FOLD -44%. MDRX -16%. OSIR -10%. NBG -5%. BBBY -5%. https://seekingalpha.com/news/730491?source=tweet\" data-url=\"https://seekingalpha.com/news/730491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730481\" data-ts=\"1356012503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold and silver slide again in a big late-year sell off taking on a curious resemblance (I, II)...</a></h4><p>Gold and silver slide again in a big late-year sell off taking on a curious resemblance (<a target=\"_blank\" href=\"http://finviz.com/futures_charts.ashx?t=GC\">I</a>, <a target=\"_blank\" href=\"http://finviz.com/futures_charts.ashx?t=SI&amp;p=d1\">II</a>) to the price action at the end of 2011. Followers of the precious metals hardly need to be reminded that bear market ended on the last trading day of the year, and was followed by a big bull run in Q1. <a href=\"https://seekingalpha.com/symbol/gld\" title=\"SPDR Gold Trust ETF\">GLD</a> <font color=\"red\">-0.9%</font>, <a href=\"https://seekingalpha.com/symbol/slv\" title=\"iShares Silver Trust ETF\">SLV</a> <font color=\"red\">-2.3%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"730481\" data-linked=\"Gold and silver slide again in a big late-year sell off taking on a curious resemblance (I, II)...\" data-tweet=\"$GLD $SLV $IAU - Gold and silver slide again in a big late-year sell off taking on a curious resemblance (I, II) to the price action at the end of 2011. Followers of the precious metals hardly need to be reminded that bear market ended on the last tradi... https://seekingalpha.com/news/730481?source=tweet\" data-url=\"https://seekingalpha.com/news/730481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730361\" data-ts=\"1356010987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYX\" target=\"_blank\">NYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on the ICE/NYSE hookup: Following the purchase, ICE plans to try and spin off Euronext -...</a></h4><p>More on the ICE/NYSE <a href=\"https://seekingalpha.com/currents/post/730311\" target=\"_blank\">hookup</a>: Following the purchase, ICE plans to try and spin off Euronext - <a href=\"https://seekingalpha.com/symbol/NYX\" title=\"NYSE Euronext\">NYX</a>'s European stock exchange operation. The <a href=\"https://seekingalpha.com/currents/post/730131\" target=\"_blank\">\"crown jewel\" </a>of this deal is NYX's European derivatives operation - the Liffe, and ICE just paid a lot to get it. <a href=\"https://seekingalpha.com/symbol/CME\" title=\"CME Group Inc.\">CME</a> Group <font color=\"green\">+0.2%</font> premarket. <a href=\"https://seekingalpha.com/symbol/ICE\" title=\"Intercontinental Exchange, Inc.\">ICE</a> <font color=\"red\">-4.1%</font> premarket, but has been halted since 90 minutes before the official announcement. NYX remains halted.</p><div class=\"tiny-share-widget\" data-id=\"730361\" data-linked=\"More on the ICE/NYSE hookup: Following the purchase, ICE plans to try and spin off Euronext -...\" data-tweet=\"$NYX $NYX $CME - More on the ICE/NYSE hookup: Following the purchase, ICE plans to try and spin off Euronext - NYX&#39;s European stock exchange operation. The &quot;crown jewel&quot; of this deal is NYX&#39;s European derivatives operation - the Liffe, and ICE just paid... https://seekingalpha.com/news/730361?source=tweet\" data-url=\"https://seekingalpha.com/news/730361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730191\" data-ts=\"1356008870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle (NYSE:ORCL) purchases cloud marketing software provider Eloqua (NASDAQ:ELOQ) for...</a></h4><p>Oracle (NYSE:<a href=\"https://seekingalpha.com/symbol/ORCL\" title=\"Oracle Corporation\">ORCL</a>) purchases cloud marketing software provider Eloqua (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ELOQ\" title=\"Eloqua\">ELOQ</a>) for $23.50/share, about $871M. Eloqua shares are halted premarket. They closed last night at $17.92. (PR)</p><div class=\"tiny-share-widget\" data-id=\"730191\" data-linked=\"Oracle (NYSE:ORCL) purchases cloud marketing software provider Eloqua (NASDAQ:ELOQ) for...\" data-tweet=\"$ORCL $ORCL $ELOQ - Oracle (NYSE:ORCL) purchases cloud marketing software provider Eloqua (NASDAQ:ELOQ) for $23.50/share, about $871M. Eloqua shares are halted premarket. They closed last night at $17.92. (PR) https://seekingalpha.com/news/730191?source=tweet\" data-url=\"https://seekingalpha.com/news/730191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730181\" data-ts=\"1356008648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on CarMax&#39;s (NYSE:KMX) Q3: Total used units rose 16% with more compelling credit offers on...</a></h4><p>More on CarMax's (NYSE:<a href=\"https://seekingalpha.com/symbol/KMX\" title=\"CarMax Group\">KMX</a>) Q3: Total used units rose 16% with more compelling credit offers on the table. On that front, CarMax Auto Finance saw its revenue increase 16% to $72.5M with managed receivable higher. The used vehicle average selling price unchanged from last year's Q3. The company now has eight of the ten superstores it planned to open in FY13 in operation. Shares <font color=\"green\">+6.2%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"730181\" data-linked=\"More on CarMax&#39;s (NYSE:KMX) Q3: Total used units rose 16% with more compelling credit offers on...\" data-tweet=\"$KMX - More on CarMax&#39;s (NYSE:KMX) Q3: Total used units rose 16% with more compelling credit offers on the table. On that front, CarMax Auto Finance saw its revenue increase 16% to $72.5M with managed receivable higher. The used vehicle average selling ... https://seekingalpha.com/news/730181?source=tweet\" data-url=\"https://seekingalpha.com/news/730181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"730051\" data-ts=\"1356007114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/730051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Rite Aid (NYSE:RAD) shoot up 19.5% in premarket action after the drugstore operator...</a></h4><p>Shares of Rite Aid (NYSE:<a href=\"https://seekingalpha.com/symbol/RAD\" title=\"Rite Aid Corporation\">RAD</a>) <font color=\"green\">shoot up 19.5%</font> in premarket action after the drugstore operator smashes estimates with its <a href=\"https://seekingalpha.com/currents/post/729951\" target=\"_blank\">Q3 report</a> by turning a small profit. The full-year outlook for a smaller loss than forecast is also putting a charge into traders.</p><div class=\"tiny-share-widget\" data-id=\"730051\" data-linked=\"Shares of Rite Aid (NYSE:RAD) shoot up 19.5% in premarket action after the drugstore operator...\" data-tweet=\"$RAD - Shares of Rite Aid (NYSE:RAD) shoot up 19.5% in premarket action after the drugstore operator smashes estimates with its Q3 report by turning a small profit. The full-year outlook for a smaller loss than forecast is also putting a charge into tra... https://seekingalpha.com/news/730051?source=tweet\" data-url=\"https://seekingalpha.com/news/730051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"729681\" data-ts=\"1355982050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRS\" target=\"_blank\">ARRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/729681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arris (NASDAQ:ARRS) finished AH trading up 16.9%, and Google (NASDAQ:GOOG) down 0.4%, following...</a></h4>Arris (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a>) finished AH trading <font color=\"green\">up 16.9%</font>, and Google (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>) <font color=\"red\">down 0.4%</font>, following the <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/729531\">Motorola Home deal</a>. In a call discussing the deal, Arris claimed Google has agreed to <a target=\"_blank\" href=\"http://techcrunch.com/2012/12/19/google-sweetened-motorola-deal-with-arris/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\">cap Arris' liability</a> in TiVo's patent suit against Motorola to \"a very small number.\" Many think the total liability could be enormous (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/688381\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/705481\">II</a>). Long-term, Arris/Motorola should be a formidable rival to Cisco's (NASDAQ:<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a>) Scientific Atlanta, but there's some potential for near-term share loss as integration issues are dealt with and customers try to re-diversify their sources.<div class=\"tiny-share-widget\" data-id=\"729681\" data-linked=\"Arris (NASDAQ:ARRS) finished AH trading up 16.9%, and Google (NASDAQ:GOOG) down 0.4%, following...\" data-tweet=\"$ARRS $ARRS $GOOG - Arris (NASDAQ:ARRS) finished AH trading up 16.9%, and Google (NASDAQ:GOOG) down 0.4%, following the Motorola Home deal. In a call discussing the deal, Arris claimed Google has agreed to cap Arris&#39; liability in TiVo&#39;s patent suit agai... https://seekingalpha.com/news/729681?source=tweet\" data-url=\"https://seekingalpha.com/news/729681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 AM </div></div></li>","count":48,"message":null,"success":true,"today":{"start":1576645200,"end":1576731599,"str":"Wednesday, December 18, 2019"},"yesterday":{"start":1576558800,"end":1576645199}}